https://www.selleckchem.com/MEK.html
To evaluate the accuracy offluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography ( F-FDG PET/CT), to correctly determine initial tumor stage in treatment-naive gastric cancer patients and to analyze the factors influencing the risk of false negative results. The baseline F-FDG PET/CT scans of 111 previously untreated gastric cancer patients were retrospectively assessed. Sensitivity, specificity, positive (PPV) and negative prediction value (NPV) were evaluated. An array of clinical, pathological and metabolic variables was